NCT05800106 2023-04-10
A Bioequivalence Study of Sunitinib Malate Capsules.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Completed
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Dana-Farber Cancer Institute
Vanderbilt-Ingram Cancer Center